Vivos Therapeutics (VVOS) Cash from Investing Activities (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.86% |
| Dec 31, 2025 | -2,004.82% |
| Sep 30, 2025 | 101.41% |
| Jun 30, 2025 | -4,740.98% |
| Mar 31, 2025 | 26.06% |
| Dec 31, 2024 | 14.06% |
| Sep 30, 2024 | -220.00% |
| Jun 30, 2024 | 60.26% |
| Mar 31, 2024 | 8.48% |
| Dec 31, 2023 | -7.14% |
| Sep 30, 2023 | 37.14% |
| Jun 30, 2023 | 15.22% |
| Mar 31, 2023 | -44.50% |
| Dec 31, 2022 | -100.00% |
| Sep 30, 2022 | 80.16% |
| Jun 30, 2022 | -320.00% |
| Mar 31, 2022 | 68.59% |
| Dec 31, 2021 | 11.57% |
| Sep 30, 2021 | 71.80% |
| Jun 30, 2021 | -484.73% |
| Mar 31, 2021 | -175.82% |
| Dec 31, 2020 | -691.31% |
| Sep 30, 2020 | -53.84% |
| Jun 30, 2020 | -49.94% |